Taken together, these results demonstrate prognostic values of ITGA1/ITGA2 loss/del and downregulation upon PCa progression to metastatic stage, suggesting that ITGA1/ITGA2 are new biomarkers that could distinguish aggressive disease and might possess tumor suppressive functions in PCa development. The gene discussed is ITGA1; the disease is posterior cortical atrophy.